price month
life scienc tool diagnost
bottom line host investor meet main defend
posit evolv veterinari suppli chain remind
tuesday cvet share fell precipit disappoint
experi well second consecut guidanc cut sinc februari
debut stand-alone public compani note by-product
henri schein anim health spin merger vet first choic
see initi vet first choic paw valuat initi coverag
neutral rate tp increment hard-
hit data point meet hone valu proposit
technology-enhanc suppli chain solut mail-ord pharmaci
competit pressur
integr disrupt proven
challeng continu point lacklust anim health demand
dynam disconnect constitu survey work
suggest may cede share distributor altern
conceptu
appeal value-ad solut view build contribut fulli
off-set near term pressur e-commerc competitor new pharmaci
offer direct manufactur relationship evolut
seemingli transpir quicker expect alongsid cvet transit
integr challeng consequ lower ebitda
estim million million million
ep
respect price target move lower view
reiter neutral cvet share vs
sinc spin maintain neutral rate await
greater visibl synergi transit cost longer term new
target price base ev/ebitda multipl
discount anim health products/servic peer adequ
reflect uniqu technolog offer well suppli chain unit risk
risk shift industri demand transit cost competit
 close
valuat metric
number share
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
one largest anim health distributor global
provid comprehens servic technolog platform
dedic support companion anim equin larg
blue sky scenario predic better
expect expans companion anim market support
innov product servic well greater
grey sky scenario assum vendor concentr
veterinari practic consolid compress margin also lower
expect revenu synergi captur veterinarian resist
wider spread accept vet first choic platform servic
price aug rate neutral target price analyst erin wright
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
 close
recap oper shortfal anoth cut outlook
result clearli disappoint revenu declin normal organ
basi weaker profit manag attribut weaker expect top
bottom line experi part lacklust north america industri fundament call
deterior veterinari patient traffic trend broad base weak across
multipl product categori importantli view commentari larg inconsist
commentari industri constitu base multipl anim health
compani track well survey work suggest potenti market share loss
distributor well altern e-commerc channel
remain focu manag commentari bright spot manag cite
strong perform across prescript manag platform build
practic enrol engag albeit still like profit drag
practic enrol vet first choic platform expand y/i
sequenti manag maintain target ad platform
custom impli ramp enrol growth practic
reach custom target end also note increas
adopt cloud-bas pim y/i repres instal base legaci
system avimark continu grow well also note therapi
manag increas vs y/i meanwhil
same-stor sale grew vs histor averag high teen in-lin
meet manag emphas value-ad platform solut
veterinarian america intern view offer
conceptu appeal take time gain meaning traction note
expand prescript manag platform intern market
said contribut vast major revenu view investor
focu like turn increasingli toward cvet core suppli chain busi near term
work transit competit challeng near term
pharmaci altern channel evolv quicker anticip view
latest call petm express under-perform chewi chwi
manag player mention develop
direct relationship manufactur sourc prescript medic addit
chwi alongsid bud pharmaci offer launch year ago may look
partner veterinarian creat prescript manag platform similar
share econom veterinarian interpret
testament vet first choic strategi view could offer increment
competit threat given chwi broad rapidli build scale said
acknowledg inher hurdl given strong neg vet bias toward
altern e-commerc player challeng face front
select veterinarian user present panel present
obvious note will work platform chwi
integr progress manag remain steadfast expect
million overal infrastructur invest target million
recur natur vs consid one-tim expens contribut part lower
previous outlin enter tsa henri schein henri schein
would provid oper corpor servic exchang fee
tsa design ensur short-term oper support establish
infrastructur termin initi tsa
remain track exit balanc tsa increment nine
term synergi realiz million million run-rat
manag continu expect run-rat cost synergi million exit year one
run-rat synergi million exit year three
recalibr expect report manag meaning lower
revenu growth target low single-digit vs previou
provid ebitda floor million vs previou million
downward revis reflect anem growth across suppli chain busi
guidanc reflect pro forma ebitda growth y/i minimum far cri
initi dd growth aspir capit market day februari note underli
market weak disconnect anim health constitu expedit
addit manag guid softer european outlook y/i cite
headwind brexit disrupt european pressur primarili isol uk
y/i note posit perform ireland belgium czech republ
off-set weak uk lower ebitda guidanc mix structur headwind
transition/integr expens includ aforement million
recur oper expens relat infrastructur invest overhead ramp
revenu impact customer/manufactur relationship loss
note ebitda growth compar basi million
minimum
prior call
cs survey vet first choicesurvey result mix longer
disclos revenu contribut vet first choic platform disappoint
dynam somewhat expect provid variou metric help
explain underli traction perform busi unit includ total therapi
manag veterinarian enrol same-stor sale
proprietari vet survey saw surpris declin vet first choic
util overtaken vetsourc main platform veterinarian offic though
note could attribut sample-s bia one-third
respond use vet first choic believ posit impact practic
revenu three respond feel neg impact top-line growth
compar user view vet first choic posit impact practic
revenu survey nice improv trend could simpli
attribut sampl view underscor e-commerc platform remain earli
stage adopt remain signific runway greater adopt
report percentag revenu anticip gener platform
next year
charl martineau univers toronto figur on-line e-commerc offer pet
third parti
compani mention price
